Terms: = Kidney tumors AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Prognosis
5 results:
1. Thioredoxin 1 (trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC.
Ribback S; Winter S; Klatte T; Schaeffeler E; Gellert M; Stühler V; Scharpf M; Bedke J; Burchardt M; Schwab M; Lillig CH; Kroeger N
World J Urol; 2022 Mar; 40(3):739-746. PubMed ID: 34859284
[TBL] [Abstract] [Full Text] [Related]
2. Loss of BAP1 protein expression in the first metastatic site predicts prognosis in patients with clear cell renal cell carcinoma.
Miura Y; Inoshita N; Ikeda M; Miyama Y; Oki R; Oka S; Kondoh C; Ozaki Y; Tanabe Y; Kurosawa K; Urakami S; Kohno T; Okaneya T; Takano T
Urol Oncol; 2017 Jun; 35(6):386-391. PubMed ID: 28284891
[TBL] [Abstract] [Full Text] [Related]
3. [Survival analysis of surgically treated renal cell carcinoma: an analysis of 10-year data from single center].
Zhang YS; Yu HY; Dong F; Li HZ
Zhonghua Wai Ke Za Zhi; 2016 Jul; 54(7):528-33. PubMed ID: 27373480
[TBL] [Abstract] [Full Text] [Related]
4. Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.
Park BJ; Cha MK; Kim IH
BMC Res Notes; 2014 Jan; 7():7. PubMed ID: 24393391
[TBL] [Abstract] [Full Text] [Related]
5. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.
Siemer S; Lehmann J; Loch A; Becker F; Stein U; Schneider G; Ziegler M; Stöckle M
J Urol; 2005 Jan; 173(1):33-7. PubMed ID: 15592020
[TBL] [Abstract] [Full Text] [Related]